About Regenerative Medical Solutions
Regenerative Medical Solutions is a company based in Chicago (United States) founded in 2011 was acquired by Medovex in January 2019.. Regenerative Medical Solutions has raised $7 million across 11 funding rounds from investors including HHS and Medovex. Regenerative Medical Solutions offers products and services including ProgenMix™ Media Formulation, ILC Cell Therapeutics, and RMS Consulting Services. Regenerative Medical Solutions operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Regenerative Medical Solutions, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Regenerative Medical Solutions
Regenerative Medical Solutions offers a comprehensive portfolio of products and services, including ProgenMix™ Media Formulation, ILC Cell Therapeutics, and RMS Consulting Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Formulation for growing stem cells to treat diabetes.
Stem cell products for pancreatic cell replacement.
Expert guidance on stem cell development for clients.
Unlock access to complete
Unlock access to complete
Funding Insights of Regenerative Medical Solutions
Regenerative Medical Solutions has successfully raised a total of $7M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series B — $5.0M
-
First Round
First Round
(20 Jun 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series B - Regenerative Medical Solutions | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - Regenerative Medical Solutions | Valuation |
investors |
|
| Mar, 2022 | Amount | Grant - Regenerative Medical Solutions | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Regenerative Medical Solutions
Regenerative Medical Solutions has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Medovex. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Products for Spinal osteoarthritis and Safe handling of patients
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Regenerative Medical Solutions
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Regenerative Medical Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Regenerative Medical Solutions Comparisons
Competitors of Regenerative Medical Solutions
Regenerative Medical Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Regenerative Medical Solutions
Frequently Asked Questions about Regenerative Medical Solutions
When was Regenerative Medical Solutions founded?
Regenerative Medical Solutions was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is Regenerative Medical Solutions located?
Regenerative Medical Solutions is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Is Regenerative Medical Solutions a funded company?
Regenerative Medical Solutions is a funded company, having raised a total of $7M across 11 funding rounds to date. The company's 1st funding round was a Grant of $259.58K, raised on Jun 20, 2013.
What does Regenerative Medical Solutions do?
Regenerative Medical Solutions was founded in 2011 in Chicago, United States. Tools and services targeted at stem cell researchers in the regenerative medicine sector are developed and commercialized. The flagship product, ProgenMix, supports the growth of pancreatic progenitor cells. Consulting services are offered to assist researchers with stem cell applications and operations.
Who are the top competitors of Regenerative Medical Solutions?
Regenerative Medical Solutions's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Regenerative Medical Solutions offer?
Regenerative Medical Solutions offers ProgenMix™ Media Formulation, ILC Cell Therapeutics, and RMS Consulting Services.